Analysis of Vitamin D in Children with Henoch-Schonlein Purpura
-
摘要:
目的 分析过敏性紫癜(henoch-schonlein purpura,HSP)患儿维生素D含量的变化。 方法 选取2022年7月至2023年7月在昆明市儿童医院就诊,符合HSP诊断的130例患儿作为研究对象,正常对照组选取同时期在昆明市儿童医院儿保科体检的100例健康儿童。收集HSP患儿及正常对照组儿童的血液标本,经昆明金域医学检验所测定各组儿童血清25(OH)D含量。 结果 HSP患儿血清25(OH)D含量较正常对照组儿童降低,差异有统计学意义(P < 0.01);HSP患儿维生素D不足率较正常对照组增高,差异有统计学意义(P < 0.01)。 结论 HSP患儿易出现维生素D不足,维生素D的补充可能为HSP的治疗提供新思路。 Abstract:Objective To analyze the changes of vitamin D in children with Henoch-Schonlein purpura(HSP). Methods 130 children with HSP from Kunming Children’ s Hospital between July 2022-July 2023 were selected as the study subjects and 100 healthy children were selected during the same period as the control group. The blood samples were collected from the children with HSP and the healthy children. The content of vitamin D was measured by Kunming Kingmed Institute for Clinical Laboratory. Results The content of 25(OH) D in children with HSP was lower than that in healthy children, and the difference was statistically significant(P < 0.01).The proportion of vitamin D insufficiency in children with HSP was higher than that in healthy children, and the difference was statistically significant(P < 0.01). Conclusion The children with HSP are prone to vitamin D insufficiency. Vitamin D supplementation may provide a new method for the treatment of HSP. -
Key words:
- Vitamin D /
- Henoch-Schonlein purpura /
- Children
-
表 1 HSP组与正常对照组25(OH)D含量的比较[($\bar x \pm s $),nmol/L]
Table 1. Comparison of 25(OH) D between HSP and control group [($\bar x \pm s $),nmol/L]
组别 25(OH)D HSP组 45.44±16.31 对照组 86.6±28.62 t 18.234 P < 0.001 * *P < 0.05。 表 2 HSP组与正常对照组25(OH)D不足率的比较
Table 2. Comparison of vitamin D deficiency in children with HSP and control group
组别 25(OH)D不足例数(n ) 25(OH)D不足比例(%) HSP组 87 66.9 对照组 5 5.0 χ2 90.304 P < 0.001 * *P < 0.05。 -
[1] 王晓川. 儿童临床免疫功能评价[J]. 实用儿科临床杂志,2008,23(21):1635-1638. [2] 罗雄燕,吴凤霞,赵岩,等. 维生素D与自身免疫性疾病[J]. 中华临床免疫和变态反应杂志,2010,4(4):312-316. [3] Dimeloe S,Rice L V,Chen H,et al. Vitamin D (1,25 ( oh)2d3) induces alpha-1-antitrypsin synthesis by cd4(+) t cells,which is required for 1,25(oh)2d3-driven il-10[J]. J Steroid Biochem Mol Biol,2019,30(189):1-9. [4] 中华医学会儿科学分会免疫学组,《中华儿科杂志》编辑委员会. 儿童过敏性紫癜循证诊治建议[J]. 中华儿科杂志,2013,51(7):502-507. [5] 中华医学会儿科学分会儿童保健学组,《中华儿科杂志》编辑委员会. 儿童微量营养素缺乏防治建议[J]. 中华儿科杂志,2010,48(7):502-509. [6] 段俊彦,葛许华. 维生素D在自身免疫性疾病及儿科应用中的研究进展[J]. 中国合理用药探索,2022,19(4):1-6. [7] Herrmann M,Farrell C L,Pusceddu I,et al. Assessment of vitamin D status -a changing landscape[J]. Clinical Chemistry and Laboratory Medicine,2016,55(1):3-26. [8] 张爱飞,冯正平. 维生素D免疫调节的研究进展[J]. 中国骨质疏松杂志,2019,25(4):564-569. [9] 李水军. 维生素D代谢及25-羟基维生素D测定方法研究进展[J]. 国际检验医学杂志,2012,33(24):3028-3030. [10] Vanherwegen A S,Gysemans C,Mathieu C. Vitamin D endocrinology on the cross-road between immunity and metabolism[J]. Molecular and Cellular Endocrinology,2017,1(453):52-67. [11] Rao Z,Zhang N,Xu N,et al. 1,25-Dihydroxyvitamin D inhibits LPS-induced high-mobility group box 1 (HMGB1) secretion via targeting the NF-E2-related factor 2-Hemeoxygenase-1- HMGB 1 pathway in macrophages[J]. Frontiers in Immunolog,2017,8(9):357. [12] 赖兰敏,彭桉平,陈曲波. 1,25二羟维生素D3的免疫调节及其在自身免疫性疾病中的研究进展[J]. 中国免疫学杂志,2019,35(17):2169-2173. doi: 10.3969/j.issn.1000-484X.2019.17.024 [13] 王颖,苏娟. 维生素D在自身免疫性疾病中的研究进[J]. 风湿病与关节炎,2017,6(2):76-80.